Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | PDE5A | O76074 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 5/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 6/20 | 0.48 |
| ▸ | MAOA | P21397 | 5/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3314128 | 0.84 | ACHE (0.71) | RAB9ANPC1ACHEKMT2AMAOB | |
| SCHEMBL3315128 | 0.84 | RAB9A (0.78) | RAB9AKDM4ENPC1PDE5AACHE | |
| SCHEMBL3312732 | 0.83 | ACHE (0.59) | ACHEKMT2A | |
| SCHEMBL3319419 | 0.80 | KDM4E (0.68) | KDM4EPDE5AACHEKMT2AMAOB | |
| SCHEMBL3314726 | 0.79 | KDM4E (0.69) | KDM4EPDE5AACHEKMT2AMAOB | |
| SCHEMBL1687448 | 0.75 | CA2 (0.55) | KDM4EATML3MBTL1KMT2ACA2 | |
| SCHEMBL15803423 | 0.72 | PDE5A (0.64) | RAB9AKDM4ENPC1PDE5AACHE | |
| SCHEMBL3308921 | 0.71 | MAOB (0.83) | ACHEKMT2AMAOBMAOACA1 | |
| SCHEMBL3319198 | 0.71 | RAB9A (1.00) | RAB9AKDM4ENPC1PDE5AATM | |
| SCHEMBL3311094 | 0.71 | RAB9A (0.83) | RAB9AKDM4ENPC1PDE5AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008045663-A2 | ARYL-SUBSTITUTED HETEROCYCLIC PDE4 INHIBITORS AS ANTIINFLAMMATORY AGENTS | KALYPSYS, INC. (US) | 2008-04-17 | — | — | WO | disclosed |